Treatment of Psychological Alcoholism with Sertraline

Initial Assessment and Treatment Framework

The American Academy of Family Physicians recommends screening for hepatic function, as naltrexone is contraindicated in patients with alcoholic liver disease due to hepatotoxicity risk 1, 2
Brief motivational interventions using the FRAMES model delivered in 5-30 minutes are recommended, and actively encouraging engagement with Alcoholics Anonymous is highly effective 1, 3

For patients without liver disease, acamprosate is the only medication with sufficient high-quality evidence demonstrating superiority over placebo for maintaining alcohol abstinence in primary care settings 1
For patients with advanced liver disease, baclofen instead of naltrexone or acamprosate is recommended, as it is safe and effective for preventing alcohol relapse 2, 3
Naltrexone and acamprosate must be avoided in advanced liver disease due to hepatotoxicity risk 2, 3

The American Academy of Family Physicians recommends starting sertraline at 25-50 mg per day and titrating to a maximum of 200 mg per day 4
Sertraline has less effect on metabolism of other medications compared to other SSRIs 4
Naltrexone dosing is recommended at 50-100 mg daily, which reduces relapse to heavy drinking and drinking frequency 1, 3

The American Academy of Family Physicians warns against using naltrexone in patients with alcoholic liver disease, as this is the most critical safety concern 1, 2
Patients with severe dependence or significant psychiatric comorbidities require more intensive professional treatment, and should not rely on AA attendance alone 1

The treatment duration should be a minimum of 12-14 weeks of combined pharmacotherapy and CBT, with follow-up every 1-3 months to assess progress, as relapse rates can reach 50% at one year 1